@SentiBio profile picture
Senti Biosciences @SentiBio

Outsmarting complex diseases with more intelligent medicines

Joined June 2016
  • Tweets 482
  • Following 92
  • Followers 2,179
418 Photos and videos
AML is the most common type of acute leukemia in adults, accounting for 80% to 85% of cases, with a 5-year survival rate of 31.7% in the United States at diagnosis. $SNTI #AML #Leukemia #Oncology
0:12
42
Don’t miss the latest from Senti Biosciences! Subscribe to email alerts for updates on our pipeline, research, and company news: bit.ly/3ZVnb39 $SNTI #Oncology #Leukemia
1
1
408
Our CEO, Tim Lu, highlighted a transformational milestone as positive FDA RMAT feedback advances SENTI-202 toward a potential registrational study in relapsed/refractory AML. Read more here: bit.ly/4wv4mCD $SNTI #AML #Oncology #CellTherapy
1
2
516
Our Chief Medical Officer, Kanya Rajangam, highlighted strong momentum for SENTI-202, supported by encouraging clinical activity, a favorable safety profile, and advancements in donor selection. Learn more: bit.ly/4wv4mCD $SNTI
1
2
327
Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program bit.ly/4wv4mCD $SNTI
1
2
605
Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal Phase bit.ly/4dpqGFi $SNTI #CellTherapy #Oncology #AML
2
147
Senti Bio was founded to build a new generation of smarter medicines designed to address complex diseases using novel and unprecedented approaches. $SNTI #AML #Oncology
1
3
744
This #WorldDNADay, we recognize the power of genetic science in advancing new approaches to cancer treatment. At Senti Bio, we’re leveraging gene circuits to drive innovation in cell and gene therapy. $SNTI #Oncology #AML
5
468
On #AMLWorldAwarenessDay, we recognize the urgency to advance research and bring forward new therapies. Because behind every diagnosis is a life, a family, and a future. We acknowledge the importance of continuing to push science forward to create new possibilities for patients.
1
7
908
Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026 bit.ly/3QgGnqb $SNTI #CellTherapy #Oncology #AML
1
1
1,098
Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies bit.ly/4cgkRue $SNTI #CellTherapy #Oncology #AML
1
5
1,121
Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update bit.ly/3PBFecv $SNTI #CellTherapy #Oncology #AML
1
2
610
Founded to develop a new generation of smarter medicines, Senti Biosciences is advancing innovative approaches to outsmart complex diseases and redefine what’s possible in medicine. $SNTI #Oncology #AML
1
2
836
Senti Biosciences to Present Clinical and Translational Data on SENTI-202 at the 11th Annual Innate Killer Conference bit.ly/4t6OzHS $SNTI #CellTherapy #Oncology #AML
46
3
1,726
Want to hear about our latest progress? Stay in the loop by signing up for our email alerts. bit.ly/3ZVnb39 $SNTI #Oncology #AML
29
1
2
1,333
Senti Biosciences is heading to the Leerink Global Healthcare Conference, March 8-11 in Miami Beach, FL! Join us for our presentation on March 9th from 2:20–2:50 PM as we share updates on our cell engineering platform and pipeline. Don't Miss It: bit.ly/3MIYyDL $SNTI
3
507
Senti Biosciences to Present at Leerink Partners 2026 Global Healthcare Conference on Monday, March 9, 2026, at 2:20 PM ET bit.ly/4ubbJ1a $SNTI #CellTherapy #Oncology #AML
3
327
Senti Bio is a clinical-stage company advancing a new generation of cell and gene therapies for patients living with incurable diseases. $SNTI #Oncology #AML
1
5
467
Senti Biosciences to Present at TD Cowen 46th Annual Health Care Conference on Monday, March 2nd at 3:10 PM ET bit.ly/4aPOAs2 $SNTI #CellTherapy #Oncology #AML
1
1
5
368
Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development bit.ly/4rZXiLe #CellTherapy #Oncology #AML
1
4
317
Load more